Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List

Executive Summary

Interim final rule redefines the terms “sole manufacturer” and “discontinuance.”

You may also be interested in...



Drug Shortage Prevention May Fall To Payers As FDA Rolls Out New Reg

Even as agency touts its progress and expands its powers, it acknowledges the limits of notification.

Compounding: How Does FDA Expand Oversight Without Legislation?

After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.

Compounding: How Does FDA Expand Oversight Without Legislation?

After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel